lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration

<div>Expression and diagnostic efficacy of PCAT14 in prostate cancer. (a) Comparison of the expression of <i>PCAT14</i> in 499 prostate cancer samples and 52 paracancer normal tissue samples. The results showed that <i>PCAT14</i> was highly expressed in prostate cancer tissues. (b) Comparison of the expression of <i>PCAT14</i> in 52 prostate cancer tissues and its matching paracancer tissues. The results showed that <i>PCAT14</i> was highly expressed in prostate cancer tissues. (c) Received operating characteristics (ROC) curve analysis showed that the area under the curve (AUC) of <i>PCAT14</i> was 0.818, indicating that <i>PCAT14</i> has a significant diagnostic ability.</div>

Disease Markers

fig1

Figure 1

Figure 1: lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration 